Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The prognostic impact of germline 46/1 haplotype of Janus kinase 2 in cytogenetically normal acute myeloid leukemia.
Nahajevszky S, Andrikovics H, Batai A, Adam E, Bors A, Csomor J, Gopcsa L, Koszarska M, Kozma A, Lovas N, Lueff S, Matrai Z, Meggyesi N, Sinko J, Sipos A, Varkonyi A, Fekete S, Tordai A, Masszi T. Nahajevszky S, et al. Among authors: kozma a. Haematologica. 2011 Nov;96(11):1613-8. doi: 10.3324/haematol.2011.043885. Epub 2011 Jul 26. Haematologica. 2011. PMID: 21791467 Free PMC article. Clinical Trial.
Additional chromosome abnormalities, BCR-ABL tyrosine kinase domain mutations and clinical outcome in Hungarian tyrosine kinase inhibitor-resistant chronic myelogenous leukemia patients.
Meggyesi N, Kozma A, Halm G, Nahajevszky S, Bátai A, Fekete S, Barta A, Ujj G, Lueff S, Sipos A, Adám E, Bors A, Reményi P, Masszi T, Tordai A, Andrikovics H. Meggyesi N, et al. Among authors: kozma a. Acta Haematol. 2012;127(1):34-42. doi: 10.1159/000331472. Epub 2011 Oct 14. Acta Haematol. 2012. PMID: 22005133
Medium-sized FLT3 internal tandem duplications confer worse prognosis than short and long duplications in a non-elderly acute myeloid leukemia cohort.
Koszarska M, Meggyesi N, Bors A, Batai A, Csacsovszki O, Lehoczky E, Adam E, Kozma A, Lovas N, Sipos A, Krahling T, Dolgos J, Remenyi P, Fekete S, Masszi T, Tordai A, Andrikovics H. Koszarska M, et al. Among authors: kozma a. Leuk Lymphoma. 2014 Jul;55(7):1510-7. doi: 10.3109/10428194.2013.850163. Epub 2013 Nov 25. Leuk Lymphoma. 2014. PMID: 24090502
Lipoprotein Lipase as a Prognostic Marker in Chronic Lymphocytic Leukemia.
Mátrai Z, Andrikovics H, Szilvási A, Bors A, Kozma A, Ádám E, Halm G, Karászi É, Tordai A, Masszi T. Mátrai Z, et al. Among authors: kozma a. Pathol Oncol Res. 2017 Jan;23(1):165-171. doi: 10.1007/s12253-016-0132-z. Epub 2016 Oct 18. Pathol Oncol Res. 2017. PMID: 27757836 Free article.
Dissection of subclonal evolution by temporal mutation profiling in chronic lymphocytic leukemia patients treated with ibrutinib.
Gángó A, Alpár D, Galik B, Marosvári D, Kiss R, Fésüs V, Aczél D, Eyüpoglu E, Nagy N, Nagy Á, Krizsán S, Reiniger L, Farkas P, Kozma A, Ádám E, Tasnády S, Réti M, Matolcsy A, Gyenesei A, Mátrai Z, Bödör C. Gángó A, et al. Among authors: kozma a. Int J Cancer. 2020 Jan 1;146(1):85-93. doi: 10.1002/ijc.32502. Epub 2019 Jun 25. Int J Cancer. 2020. PMID: 31180577 Free article.
JAK2 46/1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemia.
Andrikovics H, Nahajevszky S, Koszarska M, Meggyesi N, Bors A, Halm G, Lueff S, Lovas N, Matrai Z, Csomor J, Rasonyi R, Egyed M, Varkonyi J, Mikala G, Sipos A, Kozma A, Adam E, Fekete S, Masszi T, Tordai A. Andrikovics H, et al. Among authors: kozma a. Leukemia. 2010 Oct;24(10):1809-13. doi: 10.1038/leu.2010.172. Epub 2010 Sep 2. Leukemia. 2010. PMID: 20811399 No abstract available.
86 results